Bronchiectasis
Respiratory·MeSH: Bronchiectasis
Prevalence
30.0 / 100K
9 drugs in development·5 companies·5 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| BRINSUPRI | INSMED Inc (INSM) |
Phase 3(4)
Compare drugs
Frequently asked questions
How many drugs are in development for Bronchiectasis?
BioSniper tracks 9 drugs in development for Bronchiectasis across 5 companies.
How many clinical trials target Bronchiectasis?
There are 5 clinical trials targeting Bronchiectasis tracked by BioSniper.
What is the prevalence of Bronchiectasis?
The estimated prevalence of Bronchiectasis is approximately 30.0 per 100,000 population.
Deep-dive into Bronchiectasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis